About the Authors

Sydney Rosen

sbrosen@bu.edu

Affiliations Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America, Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Matthew P. Fox

Affiliations Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America, Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America

Bruce A. Larson

Affiliation Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America

Papa Salif Sow

Affiliations Bill & Melinda Gates Foundation, Seattle, Washington, United States of America, Department of infectious Diseases, University of Dakar, Dakar, Senegal

Peter D. Ehrenkranz

Affiliation Bill & Melinda Gates Foundation, Seattle, Washington, United States of America

Francois Venter

Affiliation Wits Reproductive Health and HIV Institute, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Yukari C. Manabe

Affiliation Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America

Jonathan Kaplan

Affiliation Independent investigator, Atlanta, Georgia, United States of America

Models for Accelerating Treatment Initiation (MATI) Technical Consultation

Participants in the Models for Accelerating Treatment Initiation (MATI) technical consultation are listed in the Acknowledgments.

Competing Interests

I have read the journal's policy and the authors of this manuscript have the following competing interests: PDE and PSS are employees of the Bill & Melinda Gates Foundation, which funded this work. FV sits on antiretroviral initiation guideline committees, both local and international. FV has accepted speaking honoraria from multiple manufacturers of antiretrovirals and is on several of their advisory boards. FV is on the editorial board of PLOS ONE and on the PLOS Human Research Advisory Group.

Author Contributions

Wrote the first draft of the manuscript: SR. Contributed to the writing of the manuscript: SR MPF BL PSS PDE FV YCM JK. Agree with the manuscript’s results and conclusions: SR MPF BL PSS PDE FV YCM JK. All authors have read, and confirm that they meet, ICMJE criteria for authorship.